Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.4.1 (
phosphodiesterase
)
18,767
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The action of excitatory amino acids (EAA) on inositol phosphates (IPs) synthesis was examined in forebrain synaptoneurosomes of Long Evans rats (6-9 days old). Glutamate (GLU) (EC50: 23 microM) and quisqualate (QA) (EC50: 0.12 microM) enhanced IPs turnover. N-methyl-D-aspartate (NMDA) and kainate (KA) were less potent. The EAA-elicited IPs response was not blocked by tetrodotoxin (2 microM) or by the absence of Ca2+. This suggests that the activation of EAA receptors stimulates directly the
phosphodiesterase
responsible for phosphoinositide breakdown. The three main agonists (QA, KA and NMDA) tested in pairs, induced additive responses on IPs accumulation. In synaptoneurosomes prepared from adult rat, the relative responses to QA and GLU were dramatically reduced, whereas those to KA and NMDA remained unchanged. We concluded that GLU stimulates IPs formation mainly via a QA-like receptor subtype (AA2). This stimulation is transient and could play a key role during synaptogenesis. GLU also enhanced IPs accumulation via other receptor subtypes (probably of the NMDA- or
AA1
-like class).
...
PMID:Characterization of subtypes of excitatory amino acid receptors involved in the stimulation of inositol phosphate synthesis in rat brain synaptoneurosomes. 282 47